Clinical Team & Medical Leadership

Physician-led care is not a credentialing line. It is the operating model.

Recovery Village's marketing leans hard on physician presence because their brochures need it to make the case. We publish the credentials, training institutions, board certifications, and clinical roles of every senior clinician on our treatment team — because skeptical referral sources (therapists, primary care providers, EAP coordinators) should be able to verify them before they send anyone to us.

Why we publish physician credentials publicly

The regional default trusts credentials it cannot see. We are making ours visible.

Most Seattle-area treatment programs describe their physician leadership with a few sentences and a headshot that may or may not be the person currently practicing at the program. The referral default — the agency most clinicians and family members name when asked "where do I send someone" — has built a credentialing position on the strength of a brand, not on the transparency of who is actually doing the clinical work. That is the gap this page is designed to close. ReGenesis publishes the credentials, training institutions, board certifications, and clinical roles of the senior clinicians on the treatment team because the alternative — treating physician leadership as a marketing claim rather than a verifiable fact — is what allowed the regional default to capture the referral market on the strength of a brochure.

What "physician-led" actually means inside the program. Physician-led is not synonymous with "a doctor is on call." A doctor on call answers a phone. A board-certified addiction-medicine prescriber on the treatment team attends the same weekly case consultation as the primary therapist, reads the same chart as the group facilitator, makes medication decisions inside the same clinical record, and has sign-off authority on the AI-personalized plan that governs the patient's care. The distinction between those two operating models is the difference between a credentialing line and an operating model. We run the second. Most regional programs run the first.

Board certification, named and verifiable. The clinicians listed below carry active board certification through the American Board of Preventive Medicine (Addiction Medicine subspecialty), the American Board of Psychiatry and Neurology, and ASAM/AAAP-recognized credentials in the addiction-medicine specialties. Training institutions, residency completion, and clinical-fellowship dates are listed so that a referral source can independently verify each credential before referring a patient. ReGenesis will share additional documentation — credentialing letters, DEA registration, state licensure, malpractice-coverage certificates — directly with a clinical professional who requests them through the contact form. That process is normal. It is what credentialing transparency looks like in practice.

EH
Dr. Elena Hartwell, MD
Medical Director
Board Certified, American Board of Preventive Medicine — Addiction Medicine
Board Certified, American Board of Internal Medicine
ASAM Fellow (FASAM)
Residency, Internal Medicine — Oregon Health & Science University
Addiction Medicine Fellowship, Stanford University School of Medicine
15+ years addiction-medicine practice; previously Associate Medical Director, Pacific Northwest Addiction Medicine Group

Dr. Hartwell joined ReGenesis as Medical Director in 2024 after fifteen years of addiction-medicine practice across hospital-based consult services, federally qualified health center MAT programs, and a six-year tenure as Associate Medical Director at the region's highest-volume addiction-medicine group practice. Her training arc — internal medicine at Oregon Health & Science University, followed by the Stanford addiction-medicine fellowship — was the foundation for an operational practice that lives at the intersection of acute medical management and longitudinal addiction care: the place where most patients enter treatment and the place where most patients fall through the cracks when an addiction-medicine presence is bolted on rather than built into the program.

Her clinical role at ReGenesis is structurally operational, not ceremonial. She attends weekly case consultation with every primary therapist, runs the medication decisions for the substance-use axis and the co-occurring-disorders axis from inside the same clinical record, signs off on the AI-personalized plan the human clinician team is operating from, and carries primary responsibility for the MAT prescribing inside the residential and intensive outpatient tracks. She is the prescriber a patient sees when buprenorphine is initiated, when naltrexone conversion is indicated, when a co-occurring mood disorder requires medication adjustment during the treatment episode, and when a discharge plan has to account for the fact that the patient will be managing a controlled-substance prescription in the post-discharge world. That is the role. The marketing version of this role — "a doctor oversees the program" — is not what the role actually is, and referral sources who are deciding whether to trust us with a patient deserve to see the operational version rather than the marketing one.

Her clinical specialty is the patient the regional default turns away at intake: MAT-stable patients entering residential, dual-diagnosis patients with active substance use, patients whose withdrawal risk has been misunderstood by previous providers. She writes and speaks regularly on the structural failures of MAT-exclusionary intake workflows and has served on the Washington State Medical Director's Addiction Treatment Quality Committee since 2021. The reason she is Medical Director of ReGenesis is not that the program needed a credentialed name — it is that the operating model ReGenesis was built to run required a medical director who is willing to do the work the role actually requires, not the work the role is usually described as doing.

Supervising clinicians
01

Dr. Marcus Yoon, MD, FASAM

Supervising Addiction Medicine Physician · Board Certified, American Board of Preventive Medicine (Addiction Medicine subspecialty) · Board Certified, American Family Medicine. Residency, Family Medicine — University of Washington School of Medicine. Addiction Medicine Fellowship, University of California, San Francisco. Clinical specialty: MAT for opioid and alcohol use disorders, complex withdrawal management, MAT induction in patients who have been previously tapered against clinical advice. Dr. Yoon runs the MAT prescriber coverage when Dr. Hartwell is off the schedule and co-leads the case-consultation review for the dual-diagnosis cohort.

02

Dr. Priya Anand, MD

Supervising Psychiatrist (Mood, Anxiety & Co-Occurring Disorders) · Board Certified, American Board of Psychiatry and Neurology · Psychiatry Residency, University of California, San Francisco. Clinical specialty: mood and anxiety disorders co-occurring with substance use, complex psychopharmacology during early recovery, psychiatric medication continuity for patients arriving on existing regimens. Dr. Anand runs the medication decisions for the mental-health axis inside the integrated case consultation — the structural reason ReGenesis is not the same as a program that "has a psychiatrist on call."

03

Jordan Reyes, LMFT, AAMFT Approved Supervisor

Lead Family & Trauma Therapist · Licensed Marriage and Family Therapist (WA, OR) · EMDRIA Certified in EMDR · Trauma-Informed Stabilization Treatment (TIST) Level III certified. MA, Marriage and Family Therapy — Antioch University Seattle. Clinical specialty: complex trauma and dissociative presentations co-occurring with substance use, family systems work, EMDR integration within ongoing addiction treatment. Mr. Reyes runs the family track and supervises the family clinician cohort.

"Counselor-led care with a physician on call is the marketing default. Physician-led care with the physician on the treatment team is the operating difference. A referral source who cannot tell the difference has been trained not to."

The structural reason ReGenesis publishes credentials is that the credentialing claim and the operating model are not the same thing, and the regional referral market has been capturing referrals on the strength of the first without being held accountable for the second. A program that names a medical director on its marketing page but routes medication decisions to a partner clinic, runs the prescriber on a part-time schedule, and runs case consultation without the prescriber in the room is admitting, by its own operating model, that the credentialing line is not the operating model. ReGenesis is built the other way around. The credentials are real because the operating model requires them to be real. When a referral source verifies the names above against the credentialing letters we share on request, the verification matches because the operating model that produces the credential is the operating model that produces the care.

If you are a clinical professional considering a referral, verify the credentials directly.

Therapists, primary care providers, EAP coordinators, and clinical professionals can request the full credentialing dossier for every senior clinician on the ReGenesis treatment team — board certification letters, state licensure, DEA registration, malpractice-coverage certificates, and current CVs. We share the documentation directly, with no sales call and no admissions intake. If the credentials hold up to a referring clinician's standard, the operational model that produced them is the operational model the patient will receive.

Request the credentialing dossier